Your browser doesn't support javascript.
loading
NK cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT.
Kanold, Justyna; Paillard, Catherine; Tchirkov, Andrei; Lang, Peter; Kelly, Antony; Halle, Pascale; Isfan, Florentina; Merlin, Etienne; Marabelle, Aurelien; Rochette, Emmanuelle; Deméocq, François.
Affiliation
  • Kanold J; CHU Clermont Ferrand, Centre Régional de Cancérologie et Thérapie Cellulaire Pédiatrique, CHU Estaing, Clermont Ferrand, France. jkanold@chu-clermontferrand.fr
Pediatr Blood Cancer ; 59(4): 739-42, 2012 Oct.
Article in En | MEDLINE | ID: mdl-22180305

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Adrenal Gland Neoplasms / Hematopoietic Stem Cell Transplantation / Immunotherapy / Neuroblastoma Type of study: Etiology_studies / Risk_factors_studies Limits: Child / Humans / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2012 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Adrenal Gland Neoplasms / Hematopoietic Stem Cell Transplantation / Immunotherapy / Neuroblastoma Type of study: Etiology_studies / Risk_factors_studies Limits: Child / Humans / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2012 Type: Article Affiliation country: France